These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1627860)

  • 21. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
    Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Madden TP; Kroeker MA
    Radiology; 1992 Nov; 185(2):479-82. PubMed ID: 1410358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
    Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
    Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy.
    Richards TL
    AJR Am J Roentgenol; 1991 Nov; 157(5):1073-8. PubMed ID: 1927795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
    AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT.
    Tanimoto A; Yuasa Y; Imai Y; Izutsu M; Hiramatsu K; Tachibana M; Tazaki H
    Radiology; 1992 Dec; 185(3):741-7. PubMed ID: 1438756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR imaging of Hippel-Lindau disease: value of gadopentetate dimeglumine.
    Nelson DR; Yuh WT; Waziri MH; Ryals TJ; Sato Y; Kao SC; Hawes DR; Williams RD
    J Magn Reson Imaging; 1991; 1(4):469-76. PubMed ID: 1790370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
    Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP
    Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetization transfer contrast in gadopentetate-dimeglumine-enhanced breast magnetic resonance imaging at 0.1 Tesla.
    Dean KI; Komu M; Dean PB; Kormano M
    Invest Radiol; 1994 Jun; 29 Suppl 2():S302-3. PubMed ID: 7928264
    [No Abstract]   [Full Text] [Related]  

  • 29. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
    Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
    Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
    De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM
    Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
    Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
    AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.
    van Gils AP; van den Berg R; Falke TH; Bloem JL; Prins HJ; Dillon EH; van der Mey AG; Pauwels EK
    AJR Am J Roentgenol; 1994 Jan; 162(1):147-53. PubMed ID: 8273654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images.
    Mirowitz SA; Shady KL
    AJR Am J Roentgenol; 1992 Aug; 159(2):385-9. PubMed ID: 1632362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadopentetate-dimeglumine-enhanced MR imaging of osteonecrosis and osteochondritis dissecans of the elbow: initial experience.
    Peiss J; Adam G; Casser R; Urhahn R; Günther RW
    Skeletal Radiol; 1995 Jan; 24(1):17-20. PubMed ID: 7709246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW; Chang KH; Choi DS; Han MH; Han MC
    AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR imaging of spondylitis with gadopentetate dimeglumine enhancement.
    Demaerel P; van Ongeval C; Wilms G; Lateur L; Baert AL
    J Neuroradiol; 1994 Dec; 21(4):245-54. PubMed ID: 7884486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
    Strouse PJ; Prince MR; Chenevert TL
    Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there any role for gadopentetate dimeglumine administration when searching for mesial temporal sclerosis in patients with seizures?
    Bronen RA
    AJR Am J Roentgenol; 1995 Feb; 164(2):503. PubMed ID: 7839999
    [No Abstract]   [Full Text] [Related]  

  • 40. Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography.
    Rofsky NM; Johnson G; Adelman MA; Rosen RJ; Krinsky GA; Weinreb JC
    Radiology; 1997 Oct; 205(1):163-9. PubMed ID: 9314979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.